Why the study?
Changes in electrocardiographic left ventricular hypertrophy after TAVI are not fully elucidated.
Does transcatheter aortic valve implantation (TAVI) reduce electrocardiographic left ventricular hypertrophy in patients with aortic stenosis?
Does transcatheter aortic valve implantation (TAVI) reduce electrocardiographic left ventricular hypertrophy in patients with aortic stenosis?
TAVI leads to significant regression of electrocardiographic left ventricular hypertrophy between 1 and 6 months post-procedure.
BACKGROUND: The changes in electrocardiographic left ventricular hypertrophy (ECG-LVH) after transcatheter aortic valve implantation (TAVI) are not fully elucidated. METHODS AND RESULTS: The study group included 64 patients who underwent TAVI for aortic stenosis. Their 12-lead ECGs before and at 2 days and 1, 6 and 12 months after TAVI were analyzed, and ECG-LVH was evaluated using various definitions. Values and prevalence of each ECG-LVH parameter significantly decreased between 1 and 6 months after TAVI. Values of ECG-LVH parameters decreased especially in patients with ECG-LVH at baseline. CONCLUSIONS: Regression of ECG-LVH was observed between 1 and 6 months after TAVI.
No takes yet. Share an insight, caveat, or question.
Tobe et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: